Sign in
Taking people in BrazilNo phase

Registry collects samples and data from young people with rare brain tumors

Collects tissue samples and health records from young people with rare brain tumors.

Key facts

Who runs it
Children's National Research Institute
Where
São Paulo, BrazilSee the siteAlso in 3 other countries, 12 sites
Trial code
Registry title
International Rare Brain Tumor Registry
Status
Recruiting
People taking part
5,800 people, planned
Started
1 Jan 2023
Expected to end
Dec 2033
Type of study
Observational, 5 groups
Record updated
7 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The registry is looking for children, teenagers and young adults with a known or suspected rare brain tumor. It collects tissue samples and health information.

Age
Up to 45 Years. The exclusion list says people older than 46 years at diagnosis cannot join.
Sex
All sexes can join.
Disease stage
A known or suspected rare brain tumor: CNS sarcoma, BCOR-altered brain tumor, astroblastoma/NM-1 altered brain tumor, or a brain tumor that is unclear or cannot be classified.

Main reasons for not taking part

  • The patient has a primary tumor outside the central nervous system (extra-CNS).
  • The patient is older than 46 years of age at diagnosis.
  • The patient or family is not willing to take part or does not sign informed consent.

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Patients with a known or suspected CNS Sarcoma
  • Patients with a known or suspected BCOR-altered brain tumor
  • Patients with a known or suspected Astroblastoma/NM-1 altered brain tumor
  • Patients with known or suspected histologically ambiguous/unclassifiable brain tumor
  • Patients with a known or suspected rare brain tumor
  • Signed informed consent by patient/ parent or guardian (assent where applicable) to participate in the study

Who cannot take part

  • The patient is older than 46 years of age at diagnosis
  • The patient has an extra-CNS primary tumor
  • The patient or family is not willing to participate or does not sign informed consent

Where in Brazil

Also in 3 other countries, 12 sites

  • TUCCA - Santa MarcelinaSão Paulo, BrazilContact: Sidnei Epelman, MDTaking people

About the trial

What the trial wants to find out

The objective of the International Rare Brain Tumor Registry (IRBTR) is to better understand rare brain tumors through the collection of biospecimens and matched clinical data of children, adolescents, and young adult patients diagnosed with rare brain tumors.

The 5 groups in the trial

  • CNS Sarcoma

    Patients diagnosed with Central nervous system (CNS) sarcomas

  • BCOR-altered

    Patients diagnosed with tumors characterized by alterations in the BCOR gene.

  • Astroblastoma/MN-1- altered

    Patients diagnosed with Astroblastomas/MN-1 alterations

  • Unclassifiable tumors

    Patients diagnosed with histologically ambiguous tumors or tumors that fail to classify with the current diagnostic methods.

  • Other Rare Brain tumors

    Patients diagnosed with other rare brain tumors that do not meet the criteria for cohorts 1-4.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
International Rare Brain Tumor Registry
Plain-language title
Registry collects samples and data from young people with rare brain tumorsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
7 August 2026